Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 06, 2024 Filed Sep 10, 2024 18:04 UTC |
Allison SchwartzDirector
|
GrantRestricted Stock Units · Derivative | 369 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016384 · form4.xml · derivative · entry 1 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 369 Underlying: Bio-Rad A Common Stock · 369 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F2 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 06, 2024 Filed Sep 10, 2024 18:01 UTC |
COREY COLLEENEVP, Global Human Resources
|
GrantRestricted Stock Units · Derivative | 2,304 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016382 · form4.xml · derivative · entry 1 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,304 Underlying: Bio-Rad A Common Stock · 2,304 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F2 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 06, 2024 Filed Sep 10, 2024 18:00 UTC |
BARRY JAMESEVP, President, LSG
|
GrantRestricted Stock Units · Derivative | 4,224 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016380 · form4.xml · derivative · entry 1 BARRY JAMES · CIK 0002022345 · EVP, President, LSG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,224 Underlying: Bio-Rad A Common Stock · 4,224 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F2 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 06, 2024 Filed Sep 10, 2024 17:57 UTC |
Crowley MichaelEVP, GBL Commercial Operations
|
GrantRestricted Stock Units · Derivative | 3,456 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016378 · form4.xml · derivative · entry 1 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,456 Underlying: Bio-Rad A Common Stock · 3,456 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F2 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 06, 2024 Filed Sep 10, 2024 17:56 UTC |
Hinckley Greg KDirector
|
GrantRestricted Stock Units · Derivative | 308 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016376 · form4.xml · derivative · entry 1 HINCKLEY GREGORY K · CIK 0001239182 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 308 Underlying: Bio-Rad A Common Stock · 308 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F2 · derivative.exercise_date: The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders. F2 · derivative.expiration_date: The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders. Read SEC document |
| September 06, 2024 Filed Sep 10, 2024 17:54 UTC |
PINKSTON ARNOLD ADirector
|
GrantRestricted Stock Units · Derivative | 308 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016374 · form4.xml · derivative · entry 1 PINKSTON ARNOLD A · CIK 0001343989 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 308 Underlying: Bio-Rad A Common Stock · 308 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F2 · derivative.exercise_date: The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders. F2 · derivative.expiration_date: The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders. Read SEC document |
| September 06, 2024 Filed Sep 10, 2024 17:53 UTC |
PEI MELINDA LITHERLANDDirector
|
GrantRestricted Stock Units · Derivative | 308 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016372 · form4.xml · derivative · entry 1 PEI MELINDA LITHERLAND · CIK 0001703469 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 308 Underlying: Bio-Rad A Common Stock · 308 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F2 · derivative.exercise_date: The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders. F2 · derivative.expiration_date: The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders. Read SEC document |
| September 06, 2024 Filed Sep 10, 2024 17:52 UTC |
EDWARDS JEFFREY LDirector
|
GrantRestricted Stock Units · Derivative | 308 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016370 · form4.xml · derivative · entry 1 EDWARDS JEFFREY L · CIK 0001190642 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 308 Underlying: Bio-Rad A Common Stock · 308 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F2 · derivative.exercise_date: The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders. F2 · derivative.expiration_date: The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders. Read SEC document |
| September 04, 2024 Filed Sep 5, 2024 00:24 UTC |
BARRY JAMESEVP, President, LSG
|
SaleBio-Rad A Common Stock | 623 | $330.49 | $205,898.14 |
DisclosureSEC source: 0001062993-24-016173 · form4.xml · nonDerivative · entry 11 BARRY JAMES · CIK 0002022345 · EVP, President, LSG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146.555 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $330.40 to $330.63, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 00:35 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Exercise / conversionRestricted Stock Units · Derivative | 2,320 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016174 · form4.xml · derivative · entry 18 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 2,320 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F9 · derivative.exercise_date: On September 3, 2019, the reporting person was granted 11,597 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F9 · derivative.expiration_date: On September 3, 2019, the reporting person was granted 11,597 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 00:35 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Tax withholdingBio-Rad A Common Stock | 1,241 | $334.31 | $414,878.71 |
DisclosureSEC source: 0001062993-24-016174 · form4.xml · nonDerivative · entry 10 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 438,238 Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 00:35 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Exercise / conversionBio-Rad A Common Stock | 2,320 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016174 · form4.xml · nonDerivative · entry 9 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 439,479 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 00:25 UTC |
COREY COLLEENEVP, Global Human Resources
|
Exercise / conversionRestricted Stock Units · Derivative | 495 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016172 · form4.xml · derivative · entry 15 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 495 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F7 · derivative.exercise_date: On September 3, 2019, the reporting person was granted 2,475 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F7 · derivative.expiration_date: On September 3, 2019, the reporting person was granted 2,475 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 00:25 UTC |
COREY COLLEENEVP, Global Human Resources
|
Tax withholdingBio-Rad A Common Stock | 177 | $334.31 | $59,172.87 |
DisclosureSEC source: 0001062993-24-016172 · form4.xml · nonDerivative · entry 10 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,479 Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 00:25 UTC |
COREY COLLEENEVP, Global Human Resources
|
Exercise / conversionBio-Rad A Common Stock | 495 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016172 · form4.xml · nonDerivative · entry 9 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,656 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 00:24 UTC |
BARRY JAMESEVP, President, LSG
|
Exercise / conversionRestricted Stock Units · Derivative | 217 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016173 · form4.xml · derivative · entry 16 BARRY JAMES · CIK 0002022345 · EVP, President, LSG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 217 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F9 · derivative.exercise_date: On September 3, 2019, the reporting person was granted 1,083 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F9 · derivative.expiration_date: On September 3, 2019, the reporting person was granted 1,083 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 00:24 UTC |
BARRY JAMESEVP, President, LSG
|
Tax withholdingBio-Rad A Common Stock | 78 | $334.31 | $26,076.18 |
DisclosureSEC source: 0001062993-24-016173 · form4.xml · nonDerivative · entry 10 BARRY JAMES · CIK 0002022345 · EVP, President, LSG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 769.555 Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 00:24 UTC |
BARRY JAMESEVP, President, LSG
|
Exercise / conversionBio-Rad A Common Stock | 217 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016173 · form4.xml · nonDerivative · entry 9 BARRY JAMES · CIK 0002022345 · EVP, President, LSG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 847.555 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 00:08 UTC |
Allison SchwartzDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 56 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016171 · form4.xml · derivative · entry 15 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 56 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F7 · derivative.exercise_date: On September 3, 2019, the reporting person was granted 279 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F7 · derivative.expiration_date: On September 3, 2019, the reporting person was granted 279 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 00:08 UTC |
Allison SchwartzDirector
|
Tax withholdingBio-Rad A Common Stock | 27 | $334.31 | $9,026.37 |
DisclosureSEC source: 0001062993-24-016171 · form4.xml · nonDerivative · entry 10 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,305 Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 00:08 UTC |
Allison SchwartzDirector
|
Exercise / conversionBio-Rad A Common Stock | 56 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016171 · form4.xml · nonDerivative · entry 9 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,332 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 13:36 UTC |
Crowley MichaelEVP, GBL Commercial Operations
|
Exercise / conversionRestricted Stock Units · Derivative | 557 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016196 · form4.xml · derivative · entry 15 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 557 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F7 · derivative.exercise_date: On September 3, 2019, the reporting person was granted 2,784 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F7 · derivative.expiration_date: On September 3, 2019, the reporting person was granted 2,784 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 13:36 UTC |
Crowley MichaelEVP, GBL Commercial Operations
|
Tax withholdingBio-Rad A Common Stock | 283 | $334.31 | $94,609.73 |
DisclosureSEC source: 0001062993-24-016196 · form4.xml · nonDerivative · entry 10 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,171 Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 13:36 UTC |
Crowley MichaelEVP, GBL Commercial Operations
|
Exercise / conversionBio-Rad A Common Stock | 557 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016196 · form4.xml · nonDerivative · entry 9 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,454 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 02, 2024 Filed Sep 5, 2024 00:35 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Exercise / conversionRestricted Stock Units · Derivative | 1,805 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016174 · form4.xml · derivative · entry 17 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 1,805 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F8 · derivative.exercise_date: On September 2, 2020, the reporting person was granted 7,220 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F8 · derivative.expiration_date: On September 2, 2020, the reporting person was granted 7,220 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 02, 2024 Filed Sep 5, 2024 00:35 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Tax withholdingBio-Rad A Common Stock | 965 | $337.32 | $325,513.80 |
DisclosureSEC source: 0001062993-24-016174 · form4.xml · nonDerivative · entry 8 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 437,159 Read SEC document |
| September 02, 2024 Filed Sep 5, 2024 00:35 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Exercise / conversionBio-Rad A Common Stock | 1,805 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016174 · form4.xml · nonDerivative · entry 7 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 438,124 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 02, 2024 Filed Sep 5, 2024 00:25 UTC |
COREY COLLEENEVP, Global Human Resources
|
Exercise / conversionRestricted Stock Units · Derivative | 361 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016172 · form4.xml · derivative · entry 14 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 361 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F6 · derivative.exercise_date: On September 2, 2020, the reporting person was granted 1,444 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F6 · derivative.expiration_date: On September 2, 2020, the reporting person was granted 1,444 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 02, 2024 Filed Sep 5, 2024 00:25 UTC |
COREY COLLEENEVP, Global Human Resources
|
Tax withholdingBio-Rad A Common Stock | 129 | $337.32 | $43,514.28 |
DisclosureSEC source: 0001062993-24-016172 · form4.xml · nonDerivative · entry 8 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,161 Read SEC document |
| September 02, 2024 Filed Sep 5, 2024 00:25 UTC |
COREY COLLEENEVP, Global Human Resources
|
Exercise / conversionBio-Rad A Common Stock | 361 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016172 · form4.xml · nonDerivative · entry 7 COREY COLLEEN · CIK 0001976271 · EVP, Global Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,290 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 02, 2024 Filed Sep 5, 2024 00:24 UTC |
BARRY JAMESEVP, President, LSG
|
Exercise / conversionRestricted Stock Units · Derivative | 265 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016173 · form4.xml · derivative · entry 15 BARRY JAMES · CIK 0002022345 · EVP, President, LSG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 265 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F8 · derivative.exercise_date: On September 2, 2020, the reporting person was granted 1,059 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F8 · derivative.expiration_date: On September 2, 2020, the reporting person was granted 1,059 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 02, 2024 Filed Sep 5, 2024 00:24 UTC |
BARRY JAMESEVP, President, LSG
|
Tax withholdingBio-Rad A Common Stock | 95 | $337.32 | $32,045.40 |
DisclosureSEC source: 0001062993-24-016173 · form4.xml · nonDerivative · entry 8 BARRY JAMES · CIK 0002022345 · EVP, President, LSG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 630.555 Read SEC document |
| September 02, 2024 Filed Sep 5, 2024 00:24 UTC |
BARRY JAMESEVP, President, LSG
|
Exercise / conversionBio-Rad A Common Stock | 265 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016173 · form4.xml · nonDerivative · entry 7 BARRY JAMES · CIK 0002022345 · EVP, President, LSG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 725.555 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 02, 2024 Filed Sep 5, 2024 00:19 UTC |
Last Andrew J.EVP, Chief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 903 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016169 · form4.xml · derivative · entry 12 Last Andrew J. · CIK 0001485088 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 903 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F7 · derivative.exercise_date: On September 2, 2020, the reporting person was granted 3,610 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F7 · derivative.expiration_date: On September 2, 2020, the reporting person was granted 3,610 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 02, 2024 Filed Sep 5, 2024 00:19 UTC |
Last Andrew J.EVP, Chief Operating Officer
|
Tax withholdingBio-Rad A Common Stock | 458 | $337.32 | $154,492.56 |
DisclosureSEC source: 0001062993-24-016169 · form4.xml · nonDerivative · entry 8 Last Andrew J. · CIK 0001485088 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,559.4501 Read SEC document |
| September 02, 2024 Filed Sep 5, 2024 00:19 UTC |
Last Andrew J.EVP, Chief Operating Officer
|
Exercise / conversionBio-Rad A Common Stock | 903 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016169 · form4.xml · nonDerivative · entry 7 Last Andrew J. · CIK 0001485088 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,017.4501 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 02, 2024 Filed Sep 5, 2024 00:08 UTC |
Allison SchwartzDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 44 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016171 · form4.xml · derivative · entry 14 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 44 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F6 · derivative.exercise_date: On September 2, 2020, the reporting person was granted 174 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F6 · derivative.expiration_date: On September 2, 2020, the reporting person was granted 174 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 02, 2024 Filed Sep 5, 2024 00:08 UTC |
Allison SchwartzDirector
|
Tax withholdingBio-Rad A Common Stock | 21 | $337.32 | $7,083.72 |
DisclosureSEC source: 0001062993-24-016171 · form4.xml · nonDerivative · entry 8 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,276 Read SEC document |
| September 02, 2024 Filed Sep 5, 2024 00:08 UTC |
Allison SchwartzDirector
|
Exercise / conversionBio-Rad A Common Stock | 44 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016171 · form4.xml · nonDerivative · entry 7 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 02, 2024 Filed Sep 5, 2024 13:36 UTC |
Crowley MichaelEVP, GBL Commercial Operations
|
Exercise / conversionRestricted Stock Units · Derivative | 434 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016196 · form4.xml · derivative · entry 14 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 434 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F6 · derivative.exercise_date: On September 2, 2020, the reporting person was granted 1,733 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F6 · derivative.expiration_date: On September 2, 2020, the reporting person was granted 1,733 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 02, 2024 Filed Sep 5, 2024 13:36 UTC |
Crowley MichaelEVP, GBL Commercial Operations
|
Tax withholdingBio-Rad A Common Stock | 155 | $337.32 | $52,284.60 |
DisclosureSEC source: 0001062993-24-016196 · form4.xml · nonDerivative · entry 8 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,897 Read SEC document |
| September 02, 2024 Filed Sep 5, 2024 13:36 UTC |
Crowley MichaelEVP, GBL Commercial Operations
|
Exercise / conversionBio-Rad A Common Stock | 434 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016196 · form4.xml · nonDerivative · entry 7 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,052 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 01, 2024 Filed Sep 5, 2024 00:35 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Exercise / conversionRestricted Stock Units · Derivative | 1,266 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016174 · form4.xml · derivative · entry 16 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,266 Underlying: Bio-Rad A Common Stock · 1,266 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F7 · derivative.exercise_date: On September 1, 2021, the reporting person was granted 5,064 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F7 · derivative.expiration_date: On September 1, 2021, the reporting person was granted 5,064 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2024 Filed Sep 5, 2024 00:35 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Exercise / conversionRestricted Stock Units · Derivative | 2,081 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016174 · form4.xml · derivative · entry 15 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,164 Underlying: Bio-Rad A Common Stock · 2,081 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F6 · derivative.exercise_date: On September 1, 2022, the reporting person was granted 8,326 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F6 · derivative.expiration_date: On September 1, 2022, the reporting person was granted 8,326 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2024 Filed Sep 5, 2024 00:35 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Exercise / conversionRestricted Stock Units · Derivative | 3,005 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016174 · form4.xml · derivative · entry 14 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,015 Underlying: Bio-Rad A Common Stock · 3,005 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: On September 1, 2023, the reporting person was granted 12,020 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F5 · derivative.expiration_date: On September 1, 2023, the reporting person was granted 12,020 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 01, 2024 Filed Sep 5, 2024 00:35 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Tax withholdingBio-Rad A Common Stock | 545 | $337.32 | $183,839.40 |
DisclosureSEC source: 0001062993-24-016174 · form4.xml · nonDerivative · entry 6 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 436,319 Read SEC document |
| September 01, 2024 Filed Sep 5, 2024 00:35 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Exercise / conversionBio-Rad A Common Stock | 1,266 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016174 · form4.xml · nonDerivative · entry 5 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 436,864 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 01, 2024 Filed Sep 5, 2024 00:35 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Tax withholdingBio-Rad A Common Stock | 801 | $337.32 | $270,193.32 |
DisclosureSEC source: 0001062993-24-016174 · form4.xml · nonDerivative · entry 4 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 435,598 Read SEC document |
| September 01, 2024 Filed Sep 5, 2024 00:35 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Exercise / conversionBio-Rad A Common Stock | 2,081 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016174 · form4.xml · nonDerivative · entry 3 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 436,399 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 01, 2024 Filed Sep 5, 2024 00:35 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Tax withholdingBio-Rad A Common Stock | 1,607 | $337.32 | $542,073.24 |
DisclosureSEC source: 0001062993-24-016174 · form4.xml · nonDerivative · entry 2 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 434,318 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.